Rare Adult & Pediatric Cancer Web Blog

Web Blog For Cancer Patients & Caregivers

Archive for December 2006

December 8th, 2006

Intraperitoneal Hyperthermic Chemotherapy (IPHC)

Filed under: Rare Cancers, General — admin @ 1:55 pm

Intraperitoneal hyperthermic chemotherapy is being used, sometimes in conjunction with cytoreductive surgery, for selected peritoneal malignancies. Here is an excellent video presentation of intraperitoneal hyperthermic chemotherapy:
Wake Forest Video Presentation

You must have Real Player installed on your computer to view this video.  For a free download of Real Player, click here.

Types of cancer/conditions treated may include:

  • Appendiceal Neoplasms with Peritoneal Dissemination
  • Peritoneal Carcinomatosis
  • Peritoneal Mesothelioma
  • Peritoneal Sarcomatosis
  • Pseudomyxoma Peritonei

Other types treated can be found here:
Dr. Sugarbaker - Current Indications For Use 

You can become a part of on of these clinical trials:

So Is IPHC right for you? Blistering, burns, tissue swelling, blood clots, bleeding , and renal dysfunction were the possible side effects quoted in some of the abstracts I read. 

Morbidity is low if this treatment is administered in specialized centers with the necessary expertise and technical resources.  Keep in mind that this procedure is still considered relatively new.  Not all facilities/physicians are using it.  If you have chosen to do this, choose a physician who has extensive experience in this procedure. 

Take Care,  Sharon  www.rare-cancer.org 

2 Comments

No comments yet.

Gamma Knife Stereotactic Radiosurgery

Filed under: General — admin @ 11:25 am

I found an excellent resource on the web for those of you who are considering gamma knife stereotactic radio surgery.  It is a comprehensive video website presentation of an actual procedure; including the entire planning process.  Make sure that you have Real Player installed on your computer.  For a free download of Real Player, click here.  Once you have Real Player installed on your computer, click here to read about this video:

Wake Forest video of gamma knife stereotactic radiosurgery

Click on the View Archived Webcast button and the video should start to download on your machine.  If you are considering this procedure, you are going to want to view this. 

In the year 2005 100,417 patients where treated with gamma knife in north and south america.  Tumors treated were both benign and malignant.  Of the 29,332 benign tumors treated, this is the breakdown:

  • Meningioma 43%
  • Vestibular Schwannoma 31%
  • Pituatary Adenoma 14%
  • Other, Benign 12%

The breakdown for the 44,960 malignant tumors treated is:

  • Metastatic Tumors 78%
  • Malignant Glial Tumors 18%
  • Other Malignant 4%

There were also 76 cases of uveal melanoma treated with gamma knife.  I can tell you that these statistics have increased considerably in 2006.

So, is this treatment right for you?  Yale-New Haven has put together a good FAQ about Gamma Knife:
Is Gamma Knife right for me?

You can also watch another video and read more information at the Leskell Gamma Knife website:
Stereotactic Radiosurgery

Now, you will at least be armed with plenty of information before making your decision.  If you choose this treatment, please come back here and share your experiences with it.

Take Care,  Sharon  www.rare-cancer.org

No Comments

No comments yet.

December 6th, 2006

Long Term Follow Up?

Filed under: Rare Cancers, Child Cancers — admin @ 6:27 pm

I was reading an abstract from Endocrinologist today, written by physicians from MD Anderson, about the importance of long term follow up in differentiated thyroid cancers (a rare form of thyroid cancer).  The abstract discussed several cases that had recurrence after 10 years of NED (no evidence of disease).

It said “Factors known to influence risk of recurrence (age at diagnosis, initial tumor size, local invasion, metastatic disease at presentation, extent of initial surgery, and radioiodine treatment) were assessed in our patients. In each case, failure to continue close follow up led to delays in diagnosis of disease recurrence.”  The point here is that early detection of recurrence could increase a person’s ability to survive. 

Another article that I read today was discussing the mental mindset of the cancer clinician; where the primary emphasis of their practice is to detect and treat.  Long term follow up has not been a priority.  It was long believed that if you survived your cancer for over 5 years, you were ‘cured’.  Statistical data was only kept for 5 years.  I am not sure who came up with this time limit, but they obviously did not treat rare cancers.

In the rare cancer world, it is not uncommon to have a cancer that is indolent (slow growing) and resident in your body for many years prior to initial detection.  And, the same can happen with recurrence or metastasis.  I have been advocating for rare cancer patients for 8 years now and I find this to be true for several cell types. 

Let me bring this back into my own personal experience.  When I was diagnosed, I had an excellent medical oncologist who told me that he honestly did not know anything about my cancer, and could not spend time doing research on it.  He needed to spend his research time on cancers that would help the most number of patients.  But, he told me that he would read any research papers that I brought to him. 

We had a wonderful relationship, based on open and honest communication.  And, I felt that I was getting good care.  He told me that I would need to be followed by him, or someone else, for the rest of my life; because of the slow growth factor of my cancer and the unknowns left from the lack of long term follow up data.

I had to move.  I have seen 3 oncologist over the last 6 years in my new area.  Two of them blatantly lied to me during my followup appointment.  They both said that they had treated many, many women with my cancer.  One said he had treated over 50 (and he was a young man).  I highly doubt that, since in the year 1995, there were only 33 cases of my cancer diagnosed in the entire United States.  I never went back to either. For me, honesty is mandatory in a doctor.

The last one, I have stayed with for 3 years. On my first visit to his office, I saw him.  Last year, I was supposed to see him, but I saw the nurse practitioner.  She had absolutely zero information on my type of cancer. The only follow up test she order was a blood test (my cancer cannot be detected this way!).  She didn’t have a clue on what tests were approprate for my follow up.  I just called to make this year’s follow-up appointment and was told that I would need to see her again.  The office girls at this practice have been told that only new patients can see the oncologists. 

I have kept data on quite a few women with my cancer over the last 8 years.  Although metastasis is uncommon; in the women who had it happen, it did not show up until their 7th to 8th year.  So, I take this 8th year of NED seriously and I want to see a doctor, not a nurse practitioner.  I want appropriate follow up procedures ordered.  But, I can’t.  Who is responsible for this, I don’t know, and I don’t care.

Statistical data on many rare cancers is far too small to come up with any conclusive info on recurrence and metastasis.  In my humble opinion, all rare cancer patients should be followed up ‘over the long haul’.  If for nothing more than the pure study of that rare disease.

The most common body site for my cancer to return is the lungs.  So, I went to my primary care physician and asked him to order a CT lung scan, with contrast.  He did and I am awaiting the results.  I will not go back to that medical oncologist.  Maybe they don’t take my cancer seriously, but I do.  I know that I might have a fighting chance against it if it is rediagnosed at an early stage. I would like to give myself the ‘best chance’ of staying alive long enough to enjoy my grandkids!

One last note: Thank You! to the doctors at MD Anderson for taking the time and effort to take a long term view of rare cancers.  You get the Hero award of the week.

Take Care,  Sharon  www.rare-cancer.org

No Comments

No comments yet.

December 5th, 2006

Farrah Fawcett’s Battle With Anal Cancer

Filed under: Support, Rare Cancers — admin @ 10:36 pm

Today’s news articles are discussing her completion of treatments (radiotherapy and chemotherapy).  The thing that is bothering me about most of the articles is their desire to make this sound like it was a ‘cake walk’ for her. After listening to members of our Anal Cancer Group, I have to tell you that I don’t think this was an easy journey for her.  So, I want to take a moment out to tell her that she is one tough cookie and I am so glad that she got through her treatment phase.  I pray that she stays in remission and is able to get on with her life.  You Go Girl!

Take Care,  Sharon  www.rare-cancer.org

1 Comment

  1. Comment by LeeAnn Jeske — February 21, 2008 @ 4:45 pm

    I had anal cancer. Found out around my birthday in
    April 2007. Went through the treatments and spent
    time in the hospital due to the burns. At last
    follow up with one of my doctors , there is no sign
    of it coming back. I thank my doctors my family
    my friends and God for standing by me.

Copyright   © Sharon Lane
Last modified: November 04, 2006 10:10:06 AM EST.
Page generated in: 0.498 seconds.
Powered by: WordPress 2.0.5